Related Experiment Video
Updated: Sep 8, 2025

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
Association of DROSHA Variants with Susceptibility and Outcomes in Childhood Acute Lymphoblastic Leukemia
Ioannis Kyriakidis1, Iordanis Pelagiadis1, Charalampos Pontikoglou2
1Department of Pediatric Hematology-Oncology & Autologous Hematopoietic Stem Cell Transplantation Unit, University Hospital of Heraklion & Laboratory of Blood Diseases and Childhood Cancer Biology, School of Medicine, University of Crete, 71003 Heraklion, Greece.
Abstract:
MicroRNAs are key regulators of lymphoid differentiation, exhibiting a pivotal role in acute lymphoblastic leukemia (ALL) biology and prognosis. The initial steps of canonical miRNA biogenesis involve the microprocessor complex processing the primary miRNA transcripts into precursor miRNAs via Drosha. DROSHA polymorphisms have been implicated in pediatric ALL and linked with cancer risk. This study investigated the role of rs642321, rs3805500, and rs10035440 DROSHA polymorphisms in ALL susceptibility, relapse, and outcomes in children and adolescents of Greek descent. The study included 252 children and adolescents (115 ALL cases and 137 controls). Genotyping was performed using RT-qPCR and the TaqMan Genotyping Assay. Homozygotes for the minor allele in DROSHA rs642321 were nominally associated with ALL susceptibility (TT vs. CC+CT; OR 4.5; 95% CI: 1.2-21.2; padj = 0.034). Likewise, homozygotes for the minor allele in rs3805500 were linked with ALL risk (GG vs. AA+AG; OR 2.7; 95% CI: 1.3-6.1; padj = 0.012). A suggestive association was observed between the rs3805500 AG genotype and both relapsed (OR 5.8; 95% CI: 1.6-24.3; padj = 0.011) and deceased cases (OR 5; 95% CI: 1.1-26.3; padj = 0.038). Patients with the rs3805500 AG and GG genotypes showed a trend toward poorer overall survival rates. In summary, certain haplotypes of DROSHA polymorphisms may be modestly associated with the occurrence of childhood ALL and its outcomes, although these findings require validation in larger, independent cohorts.
Insights
Certain DROSHA gene polymorphisms may influence childhood acute lymphoblastic leukemia (ALL) risk and outcomes in Greek children. Further studies are needed to confirm these associations with pediatric ALL.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- MicroRNAs are crucial regulators in lymphoid differentiation and play a significant role in acute lymphoblastic leukemia (ALL) biology and prognosis.
- The microprocessor complex, involving Drosha, processes primary miRNA transcripts into precursor miRNAs, a key step in miRNA biogenesis.
- DROSHA gene polymorphisms have been previously linked to pediatric ALL and cancer risk.
Purpose of the Study:
- To investigate the association of specific DROSHA polymorphisms (rs642321, rs3805500, rs10035440) with ALL susceptibility in children and adolescents of Greek descent.
- To evaluate the role of these DROSHA polymorphisms in relation to relapse and overall outcomes in pediatric ALL patients.
Main Methods:
- A case-control study involving 252 children and adolescents (115 ALL cases, 137 controls) of Greek descent.
- Genotyping of DROSHA polymorphisms rs642321, rs3805500, and rs10035440 was performed using RT-qPCR and the TaqMan Genotyping Assay.
Main Results:
- Homozygotes for the minor allele of DROSHA rs642321 showed a nominal association with increased ALL susceptibility (OR 4.5, padj = 0.034).
- Homozygotes for the minor allele of DROSHA rs3805500 were linked to a higher risk of ALL (OR 2.7, padj = 0.012).
- The rs3805500 AG genotype was suggestively associated with relapse (OR 5.8, padj = 0.011) and deceased cases (OR 5, padj = 0.038), with a trend towards poorer overall survival for AG and GG genotypes.
Conclusions:
- Specific DROSHA gene polymorphisms may be modestly associated with the susceptibility to childhood ALL in the studied Greek population.
- Certain DROSHA genotypes appear linked to adverse outcomes, including relapse and survival, in pediatric ALL patients.
- These findings warrant validation in larger, independent cohorts to confirm the role of DROSHA polymorphisms in pediatric ALL.
More Related Videos
06:41In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Related Concept Videos
Oppositional Defiant Disorder
Diagnostic Criteria and...
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...